SG Americas Securities’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,906
Closed -$163K 3217
2025
Q4
$163K Buy
19,906
+2,624
+15% +$23.7K ﹤0.01% 3013
2025
Q3
$153K Buy
+17,282
New +$109K ﹤0.01% 2893
2025
Q2
Sell
-18,698
Closed -$101K 2936
2025
Q1
$101K Sell
18,698
-5,668
-23% -$26.7K ﹤0.01% 3041
2024
Q4
$111K Buy
24,366
+5,031
+26% +$25.8K ﹤0.01% 2655
2024
Q3
$101K Buy
+19,335
New +$87.4K ﹤0.01% 3071
2024
Q2
Sell
-13,476
Closed -$34K 2848
2024
Q1
$34K Sell
13,476
-10,465
-44% -$25.3K ﹤0.01% 2818
2023
Q4
$64K Buy
23,941
+4,721
+25% +$9K ﹤0.01% 2878
2023
Q3
$23K Buy
+19,220
New +$29.8K ﹤0.01% 3034
2023
Q2
Sell
-15,864
Closed -$16K 2303
2023
Q1
$16K Sell
15,864
-13,477
-46% -$16K ﹤0.01% 3172
2022
Q4
$23K Buy
29,341
+3,500
+14% +$3.66K ﹤0.01% 2917
2022
Q3
$39K Buy
25,841
+9,183
+55% +$18.9K ﹤0.01% 3030
2022
Q2
$38K Buy
+16,658
New +$48.3K ﹤0.01% 3297
2021
Q4
Sell
-14,342
Closed -$115K 3374
2021
Q3
$115K Buy
+14,342
New +$139K ﹤0.01% 3598

Other funds holding AVAH

SG Americas Securities's AVAH Position: Q1 2026 in Review

SG Americas Securities sold out of Aveanna Healthcare (AVAH) in Q1 2026, closing a stake of 19,906 shares — an estimated $163K sold.

SG Americas Securities first reported a position in AVAH in Q3 2021 and held it in 13 quarters. The position peaked at $163K in Q4 2025. 199 funds tracked by Wall St. Rank hold AVAH as of Q1 2026.

  • SG Americas Securities reported no remaining Aveanna Healthcare position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 19,906 Aveanna Healthcare shares in Q1 2026, an estimated $163K.
  • SG Americas Securities first reported a position in Aveanna Healthcare in Q3 2021 and held it in 13 quarters.
  • SG Americas Securities's Aveanna Healthcare position peaked at $163K in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.